Medical device makers have bankrolled a cottage industry of doctors and clinics that perform artery-clearing procedures that can lead to amputations.
Tag: Medicare
-
What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA
Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.
-
FDA Makes Alzheimer’s Drug Leqembi Widely Accessible
The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.
-
People With Private Medicare Plans Can’t Find Psychiatrists, Study Shows
A new study finds that people have a very difficult time finding doctors in their networks under the private-sector policies.
-
States Try Easing the Burden of Long-Term Care’s High Cost
Seeing their own financial benefits, too, Washington and California are among the states creating programs to help older residents.